Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,002.00
Bid: 12,000.00
Ask: 12,004.00
Change: 72.00 (0.60%)
Spread: 4.00 (0.033%)
Open: 12,108.00
High: 12,142.00
Low: 11,994.00
Prev. Close: 11,930.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 rises after BoE's new rescue measures, midcaps stuck in the red

Thu, 19th Mar 2020 10:48

* FTSE bounces after BoE eases again

* Recent sterling slide helps exporters, banks also gain

* Joules, Playtech, Crest Nicholson scrap dividend

* FTSE 100 up 1.4%, FTSE 250 down 1.4%
(Updates with closing prices)

By Sruthi Shankar

March 19 (Reuters) - Britain's top shares ended a volatile
session higher on Thursday after the Bank of England cut
interest rates to a record low and ramped up its bond-buying
programme in a bid to rescue the economy from the coronavirus
crisis.

After wild swings earlier in the day, the blue-chip FTSE 100
rose 1.4%, with big dollar earners such as Diageo
, Royal Dutch Shell and AstraZeneca
providing the biggest boost, even as the pound recovered from a
35-year low.

The central bank cut interest rates to 0.1%, its second
emergency rate cut in just over a week, and promised 200 billion
pounds of additional bond purchases, and at a much faster pace
than normal.

The moves follow similar drastic measures by other central
banks and governments, including a 330 billion-pound stimulus
package from the UK government earlier this week, to inject
liquidity into markets and stem an economic slowdown, which many
fear may have already pushed the global economy into a short
slump.

"We would not be surprised if the BoE's announcement
prepares the ground for more fiscal announcements soon,"
Citigroup's Christian Schulz wrote in a note.

"We expect further programmes to absorb households' income
losses due to the COVID-19 crisis and eventually also stimulus
and debt forgiveness for companies."

The announcement, however, failed to pull midcap stocks out
of their misery. The FTSE Mid 250 index dropped 1.4% for
its eleventh day of losses after Prime Minister Boris Johnson
enforced tougher measures to contain the virus.

"This (stimulus measures) will help at the margin,
particularly the fiscal spend, if they can find a way to get the
money to businesses and individuals," a fund manager at a UK-
based asset manager said.

"For confidence to meaningfully turn more positive, we need
to see the rate of infection slow in Western markets."

Shares in homebuilder Crest Nicholson slumped 30%
after it cancelled payment of its final dividend along with
financial forecasts for 2020.

Fashion retailer Joules Group and gambling software
maker Playtech also announced similar measures.

A leading ventilator manufacturer, Hamilton Medical, told
Reuters that Britain faces a "massive shortage" of the
ventilators that will be needed to treat critically ill patients
suffering from coronavirus.

Luxury brand Burberry Group warned that sales in
the final weeks of March would plunge by around 70% to 80%
compared to last year.

Pub operator Young & Co's Brewery Plc fell 5.2%
after it said that the closure of some or all of its pubs for at
least a short period was "imminent".

Next rose 5.3% after the clothing retailer said it
could sustain a hit from the coronavirus outbreak of more than 1
billion pounds ($1.2 billion) without exceeding its debt and
bank facilities.
(Reporting by Sruthi Shankar and Devik Jain in Bengaluru;
Editing by Bernard Orr, Saumyadeb Chakrabarty, Kirsten Donovan)

More News
23 Oct 2023 08:45

TOP NEWS: AstraZeneca says Enhertu approved by European Commission

(Alliance News) - AstraZeneca PLC on Monday said its Enhertu treatment has been approved by the European Commission to treat adult lung cancer patients.

Read more
23 Oct 2023 07:46

LONDON BRIEFING: Keller expects higher profit; Upland rejects approach

(Alliance News) - Stocks in London are set to open slightly higher on Monday, as risk sentiment improves after a difficult period for markets last week.

Read more
18 Oct 2023 09:04

AstraZeneca drug Solaris approved in China as NMOSD treatment

(Alliance News) - AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder

Read more
17 Oct 2023 12:06

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

Read more
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
25 Sep 2023 07:43

LONDON BRIEFING: Stocks seen lower; Aviva buys AIG's UK protection arm

(Alliance News) - Stocks in London were set to open lower on Monday as investors eyed fresh concerns for the already fragile Chinese property sector.

Read more
22 Sep 2023 08:42

LONDON MARKET OPEN: Stocks slip after central bank rate calls

(Alliance News) - Stock prices in London opened lower on Friday, but managed to avoid the steep declines seen in New York, as investors mulled over an eventful week dominated by central bank decisions.

Read more
22 Sep 2023 08:13

TOP NEWS: AstraZeneca's datopotamab deruxtecan shows positive results

(Alliance News) - AstraZeneca PLC on Friday said phase three data showed that datopotamab deruxtecan delivered improvement in progression-free survival in breast cancer patients.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.